Patent Holder

Jonathan Dinman

Jonathan Dinman
U.S. Patent 7,235,715. Virus-resistant transgenic plants expression L3.
U.S. Patent 6,989,294. Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof.
U.S. Patent 6,989,256. Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof.
U.S. Patent application 20070059684. Method of identifying an antiviral agent.
U.S. Patent application 20050277607. Compositions and methods for regulating peptidyltransferase activity and uses thereof.
European patent 06123301.1-2107: “Proteins Involved in Targeting of Peptidyl Transfer Center and Corresponding Therapeutic Agents and Methods.” Inventors: S.W. Peltz, Y. Cui, and J.D. Dinman and. Filed: October 10, 1996. Patent awarded March 12, 2007.
University of Maryland patent application LS-2005-031: A Dual Fluorescent Reporter System Designed For Inexpensive, High Throughput Identification Of Anti-Viral Agents. Inventors: J. D. Dinman, and A. Petrov.
University of Maryland patent application LS-2006-042: Single Nucleotide Polymorphisms and Programmed Ribosomal Frameshifting. Inventor: J.D. Dinman.
University of Maryland patent application LS-2007-092: A New Application of Aminoglycoside Antibiotics for Treatment of Viral Diseases.
University of Maryland patent application LS-2008-021: Creation of xylose fermenting strains of the yeast Saccharomyces cerevisiae to produce ethanol from hemicelluloses.